ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Four of the five patients with pathogenic somatic ABL1 kinase domain (KD) variants, including two cases harbouring two variants at the same time, were found in the group of patients with secondary CML‐BP.